DISOMER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Disomer, and when can generic versions of Disomer launch?
Disomer is a drug marketed by Schering and is included in one NDA.
The generic ingredient in DISOMER is dexbrompheniramine maleate. There are seven drug master file entries for this compound. Additional details are available on the dexbrompheniramine maleate profile page.
Summary for DISOMER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 60 |
Patent Applications: | 308 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DISOMER at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DISOMER
US Patents and Regulatory Information for DISOMER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | DISOMER | dexbrompheniramine maleate | SYRUP;ORAL | 011814-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | DISOMER | dexbrompheniramine maleate | TABLET;ORAL | 011814-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |